5.4 Combination of systemic therapy and immunotherapy in HCC Before ICI immunotherapy had modified the management of HCC in the past few years, around 50% of patients with HCC received systemic therapies, generally, sorafenib or lenvatinib in the first line, followed by regorafenib, cabozantinib or ramucirumab as the second
Vitamin C The level of vitamin C is higher in the central nervous system than in plasma and positively affects cognitive functions and memory
In another study, compared to the control group, GHK treatment groups (1 or 10 mg/kg) demonstrated decreased neuronal apoptosis and neurological deficits in rat brains induced by intracerebral hemorrhage (ICH) injury
We show that hepatic sulfur amino acid (SAA) metabolism is under transcriptional control of HNF4
Its a great choice for those seeking daily digestive support with added benefits for appetite control
Improper storage is one of the most common reasons research compounds lose potency before a study even begins, so this step matters more than people expect
